When your blood sugar is rising again
An alternate version called Rybelsus was approved in September 2019, also as a Type 2 diabetes treatment, and semaglutide received approval for weight loss in June 2021 under the brand name Wegovy
Laboratory studies have also shown that GLP-1 agonists may directly inhibit cancer cell growth and alter metabolic pathways essential to tumor survival
People with certain medical conditions may require additional screening before taking sermorelin and sometimes should avoid this therapy
Rothfuss A, Schuetz P, Bochum S, Volm T, Eberhardt E, Kreienberg R, Vogel W, Speir G: Induced micronucleus frequencies in peripheral lymphocytes as a screening test for carriers of a BRCA1 mutation in breast cancer families